Tenet Healthcare AI Stock Analysis
Want to see THC full AI Analyst Report?
Tenet Healthcare (THC) AI Stock Analysis
Tenet Healthcare
(NYSE:THC)
The score is driven by strong recent financial performance (notably margins and free cash flow) and a constructive technical uptrend. Valuation is supportive given the low P/E. Offsetting factors are balance-sheet trend discontinuity and earnings-call risks tied to exchange/Medicaid headwinds and nonrecurring Conifer transition benefits.
Tenet Healthcare Key Performance Indicators (KPIs)
Revenue by SegmentBreaks down income from different business areas, offering insight into which segments are driving growth and profitability. This can reveal strategic focus areas and potential vulnerabilities in the business model.
Ambulatory Care (USPI) is the durable growth engine—margin and revenue‑per‑case strength plus a shift to higher‑acuity cases underpin the beat-and-raise and justify continued USPI M&A, while Hospital Operations show improving admissions and revenue per admission but remain vulnerable to localized exchange enrollment losses and reimbursement risk. The abrupt removal of Conifer and intersegment eliminations reflects portfolio/accounting changes that clear up consolidated top‑line comparability but introduce timing volatility (supplemental Medicaid/out‑of‑period items); monitor payer mix and rising professional fees as the main downside risks.
Tenet Healthcare (THC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $22.45B
- Dividend Yield
- ―
- Average Volume (3M)
- 778.82K
- Price to Earnings (P/E)
- 8.2
- Beta (1Y)
- 0.81
- Revenue Growth
- 6.23%
- EPS Growth
- 136.09%
- Country
- US
- Employees
- 88,500
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Tenet Healthcare Business Overview & Revenue Model
Company Description
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care fac...
How the Company Makes Money
Tenet Healthcare primarily makes money by providing healthcare services that are reimbursed by commercial insurers, government payors (e.g., Medicare and Medicaid), and patients (self-pay). Its revenue model is largely fee-for-service: Tenet bills pa...
Tenet Healthcare Earnings Call Summary
The call was strongly positive overall. Tenet delivered substantial earnings, margin, cash flow, and share-repurchase performance; raised its 2026 revenue, EBITDA, and free cash flow guidance; and expressed confidence in core EBITDA growth for 2027. The principal challenges were exchange-related volume and coverage pressure, lower USPI case volumes, the nonrecurring nature of Conifer transition contributions, and uncertainty surrounding Medicaid work requirements, HR 1, and future regulatory conditions.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Tenet expects consolidated net operating revenues in the range of $22.05 to $22.45 billion, adjusted EBITDA in the range of $5.05 to $5.2 billion, and adjusted free cash flow after NCI in the range of $1.925 to $2.155 billion, including the payment of $150 million in tax payments this year for the Conifer transaction; excluding these tax payments, this would represent $2.2 billion of adjusted free cash flow after NCI at the midpoint of our 2026 outlook. Various transition activities at Conifer are expected to total $450 million of adjusted EBITDA in 2026, and these contributions are not expected to recur in 2027. After excluding the impact of the transition activities at Conifer, Tenet expects its enterprise to deliver overall adjusted EBITDA growth in 2027, assuming the current known regulatory frameworks; USPI should not be materially impacted by exchange headwinds and Medicaid work requirements, with same store revenue growth, consistent margins, and further expansion of the asset portfolio, while the hospital segment currently sees healthy patient demand that would support same store volume growth and a stable operating environment supported by disciplined cost controls.
Tenet Healthcare Financial Statement Overview
Summary
Profitability and cash generation are strong (TTM net margin ~14%, EBITDA margin ~21.6%, TTM FCF ~$3.33B with ~79% FCF-to-net-income conversion). The main offset is balance-sheet trend inconsistency—leverage appears dramatically better in TTM versus prior years, creating durability/quality risk around the step-change.
Income Statement
86Very PositiveBalance Sheet
72PositiveCash Flow
83Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.80B | 21.31B | 20.66B | 20.55B | 19.17B | 19.48B |
| Gross Profit | 6.70B | 17.53B | 8.21B | 7.80B | 7.05B | 7.27B |
| EBITDA | 5.92B | 4.48B | 6.89B | 3.39B | 3.08B | 3.67B |
| Net Income | 2.90B | 1.41B | 3.20B | 611.00M | 411.00M | 914.00M |
Balance Sheet | ||||||
| Total Assets | 31.59B | 29.68B | 28.94B | 28.31B | 27.16B | 27.58B |
| Cash, Cash Equivalents and Short-Term Investments | 2.67B | 2.88B | 3.02B | 1.23B | 858.00M | 2.36B |
| Total Debt | 13.24B | 13.17B | 14.33B | 15.00B | 15.08B | 15.65B |
| Total Liabilities | 22.00B | 20.70B | 20.39B | 22.80B | 22.55B | 23.32B |
| Stockholders Equity | 5.44B | 4.22B | 4.17B | 1.61B | 1.14B | 1.03B |
Cash Flow | ||||||
| Free Cash Flow | 3.33B | 2.53B | 1.12B | 1.62B | 321.00M | 910.00M |
| Operating Cash Flow | 4.24B | 3.54B | 2.05B | 2.37B | 1.08B | 1.57B |
| Investing Cash Flow | -1.21B | -1.27B | 3.43B | -969.00M | -808.00M | -714.00M |
| Financing Cash Flow | -3.33B | -2.40B | -3.69B | -1.03B | -1.78B | -936.00M |
Tenet Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For THC, the sentiment is Positive. The current price of 282.07 is above the 20-day moving average (MA) of 278.39, above the 50-day MA of 268.84, and above the 200-day MA of 225.81, indicating a bullish trend. The MACD of 6.04 indicates Negative momentum. The RSI at 53.58 is Neutral, neither overbought nor oversold. The STOCH value of 46.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for THC.
Tenet Healthcare Risk Analysis
Tenet Healthcare disclosed 25 risk factors in its most recent earnings report. Tenet Healthcare reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksTenet Healthcare Peers Comparison
Overall Rating
THC83Outperform
UHS76Outperform
ARDT68Neutral
HCA64Neutral
SGRY51Neutral
CYH44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $22.45B | 8.16 | 60.60% | ― | 6.23% | 136.09% | |
| 76Outperform | $11.07B | 8.01 | 19.54% | 0.42% | 8.00% | 13.14% | |
| 68Neutral | $2.50B | 17.08 | 9.48% | ― | 2.03% | -28.50% | |
| 64Neutral | $104.69B | 16.52 | -100.45% | 0.61% | 5.82% | 16.59% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | $3.51B | -40.04 | -5.17% | ― | 2.19% | 50.06% | |
| 44Neutral | $284.87M | 7.57 | -2.51% | ― | -7.84% | -88.93% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| THC | Tenet Healthcare Corp. | 282.07 | 95.39 | 51.10% | |
| CYH | Community Health Systems | 2.02 | -0.92 | -31.29% | |
| HCA | Hca Healthcare | 501.19 | 28.15 | 5.95% | |
| UHS | Universal Health Services | 191.98 | -32.42 | -14.45% | |
| SGRY | Surgery Partners Inc. | 26.85 | 11.55 | 75.49% | |
| ARDT | Ardent Health Partners, Inc. | 17.75 | 9.11 | 105.44% |
Tenet Healthcare Corporate Events
Tenet Healthcare Issues New Senior Notes to Refinance Debt
PositiveOn September 22, 2026, Tenet Healthcare Corporation issued $2 billion of 6.250% senior notes due 2034 under its existing indenture structure with The Bank of New York Mellon Trust Company as trustee. The company plans to use the net proceeds, togethe...
Tenet Healthcare Announces Major 2034 Senior Notes Offering
PositiveOn September 8, 2026, Tenet Healthcare announced a private placement offering of $1.5 billion in new senior notes due 2034, followed by an upsized and priced $2.0 billion issuance of 6.250% senior notes due 2034. The notes will be unsecured obligatio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
